//
Provides funding for general research, translational research, and other research or development projects for research organizations and academic institutions.
Funding for non-healthcare-related programs focused on humanitarian and social issues, science education, or the community and environment. Requests must be submitted at least 60 days before the project start date.
Genentech Patient Foundation is a private corporation based in S SAN FRAN, CA. The foundation received its IRS ruling in 2003. The principal officer is % Doug Mcintosh. It holds total assets of $424.1M. Annual income is reported at $3.7B. DISTRIBUTION OF PHARMACEUTICAL PRODUCTS TO ELIGIBLE UNINSURED OR UNDERINSURED PATIENTS IN THE UNITED STATES. DURING 2021, THE GENENTECH PATIENT FOUNDATION PROVIDED. According to available records, Genentech Patient Foundation has made 4 grants totaling $12.8B, with a median grant of $3.2B. Annual giving has grown from $2.9B in 2020 to $3.5B in 2023. Grantmaking activity was highest in 2022 with $6.4B distributed across 2 grants. Individual grants have ranged from $2.9B to $3.5B, with an average award of $3.2B. Grant recipients are concentrated in California. Contributions to this foundation are tax-deductible.
DISTRIBUTION OF PHARMACEUTICAL PRODUCTS TO ELIGIBLE UNINSURED OR UNDERINSURED PATIENTS IN THE UNITED STATES. DURING 2020, THE GENENTECH PATIENT FOUNDATION PROVIDED
Expenses: $3B
$3 BILLION WORTH OF PRESCRIPTION DRUGS TO PATIENTS.
DISTRIBUTION OF PHARMACEUTICAL PRODUCTS TO ELIGIBLE UNINSURED OR UNDERINSURED PATIENTS IN THE UNITED STATES. DURING 2021, THE GENENTECH PATIENT FOUNDATION PROVIDED. Based on available records, the foundation has funded 4 grants. Its grantmaking reaches organizations primarily in CA.
Genentech Patient Foundation has distributed a total of $12.8B across 4 grants. The median grant size is $3.2B, with an average of $3.2B. Individual grants have ranged from $2.9B to $3.5B.
The application deadline is See Schedule # 2 attached.. See Schedule # 2 attached.
Genentech Patient Foundation is headquartered in S SAN FRAN, CA.
| Name | Title | Compensation | Benefits | Total |
|---|---|---|---|---|
| See Schedule 1 | — | $0 | $0 | $0 |
Total Giving
$3.7B
Total Assets
$337.6M
Fair Market Value
$337.6M
Net Worth
$230.8M
Grants Paid
$3.6B
Contributions
$3.7B
Net Investment Income
$0
Distribution Amount
$0
Total Grants
4
Total Giving
$12.8B
Average Grant
$3.2B
Median Grant
$3.2B
Unique Recipients
1
Most Common Grant
$3.2B
of 2023 grantees were first-time recipients
| Recipient | Location | Amount | Year |
|---|---|---|---|
| Eligible Patients (See Schedule #2)Provide Prescription Drugs | South San Francisco, CA | $3.5B | 2023 |
NEW BRUNSWICK, NJ
WHIPPANY, NJ
EAST HANOVER, NJ
INDIANAPOLIS, IN
Supports independent medical education for healthcare professionals (HCPs) to improve the knowledge of the medical community and advance excellence in medicine. Programs must be independent and follow ACCME standards.
Supports healthcare-related programs and events consistent with therapeutic areas active for Genentech. Includes patient outreach, screenings, and disease education.
Supports independent charitable foundations that provide co-pay assistance to patients who cannot afford out-of-pocket costs for medicines. Organizations must have a favorable OIG opinion.
© 2026 Granted AI